NO20063917L - Fremgangsmate for syntese av N-[3-(3-cyanopyrazol[1,5A]pyrimidin-7-yl)-fenyl]-N-etyl-acetamid - Google Patents
Fremgangsmate for syntese av N-[3-(3-cyanopyrazol[1,5A]pyrimidin-7-yl)-fenyl]-N-etyl-acetamidInfo
- Publication number
- NO20063917L NO20063917L NO20063917A NO20063917A NO20063917L NO 20063917 L NO20063917 L NO 20063917L NO 20063917 A NO20063917 A NO 20063917A NO 20063917 A NO20063917 A NO 20063917A NO 20063917 L NO20063917 L NO 20063917L
- Authority
- NO
- Norway
- Prior art keywords
- formula
- phenyl
- ethyl
- acetamide
- synthesis
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title abstract 4
- 238000003786 synthesis reaction Methods 0.000 title abstract 4
- YMJLEPMVGQBLHL-UHFFFAOYSA-N 1h-pyrazole-5-carbonitrile Chemical compound N#CC1=CC=NN1 YMJLEPMVGQBLHL-UHFFFAOYSA-N 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 239000012535 impurity Substances 0.000 abstract 3
- FZSDJRKAWHMQFF-UHFFFAOYSA-N n-[3-[3-(dimethylamino)prop-2-enoyl]phenyl]-n-ethylacetamide;hydrochloride Chemical compound Cl.CCN(C(C)=O)C1=CC=CC(C(=O)C=CN(C)C)=C1 FZSDJRKAWHMQFF-UHFFFAOYSA-N 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- FFNKBQRKZRMYCL-UHFFFAOYSA-N 5-amino-1h-pyrazole-4-carbonitrile Chemical compound NC1=NNC=C1C#N FFNKBQRKZRMYCL-UHFFFAOYSA-N 0.000 abstract 1
- -1 pyrimidine-1-yl Chemical group 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Anesthesiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0400325A HUP0400325A3 (en) | 2004-02-02 | 2004-02-02 | Pure n-[3-(-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethyl-acetamide, process for its preparation and intermediates |
PCT/HU2005/000008 WO2005073235A2 (fr) | 2004-02-02 | 2005-01-31 | Procede de synthese de n- [3-(3-cyanopyrazolo [1,5a] pyrimidin-7-yl)-phenyl]-n-ethyl-acetamide |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20063917L true NO20063917L (no) | 2006-11-01 |
Family
ID=89981959
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20063917A NO20063917L (no) | 2004-02-02 | 2006-09-01 | Fremgangsmate for syntese av N-[3-(3-cyanopyrazol[1,5A]pyrimidin-7-yl)-fenyl]-N-etyl-acetamid |
Country Status (9)
Country | Link |
---|---|
EP (2) | EP1950213B1 (fr) |
JP (1) | JP2007519700A (fr) |
AT (2) | ATE420882T1 (fr) |
DE (2) | DE602005012365D1 (fr) |
EA (1) | EA010830B1 (fr) |
HU (1) | HUP0400325A3 (fr) |
NO (1) | NO20063917L (fr) |
RS (1) | RS20060427A (fr) |
WO (1) | WO2005073235A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005099712A2 (fr) * | 2004-04-19 | 2005-10-27 | Sanmar Speciality Chemicals Limited | Procede de preparation de n-[3-(3-cyanopyrazolo [1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide |
WO2006070244A2 (fr) * | 2004-11-22 | 2006-07-06 | Bakulesh Mafatlal Khamar | Processus de preparation de zaleplon |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4626538A (en) | 1983-06-23 | 1986-12-02 | American Cyanamid Company | [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines |
US5714607A (en) * | 1995-12-01 | 1998-02-03 | American Cyanamid Company | Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide |
WO2002100828A2 (fr) * | 2001-06-12 | 2002-12-19 | Biogal Gyogyszergyar Rt | Procede pour la production de n-[3-(3-cyanopyrazolo[1,5-a] pyrimidine-7-yle)phenyle]-n-ethylacetamide (zaleplon) |
US6852858B2 (en) * | 2001-08-01 | 2005-02-08 | Biogal Gyogyszergyar Rt. | Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide (zaleplon) and crystalline forms of zaleplon accessible with the process |
PL207322B1 (pl) * | 2002-05-14 | 2010-11-30 | Adamed Społka Z Ograniczoną Odpowiedzialnością | Sposób wytwarzania zaleplonu |
-
2004
- 2004-02-02 HU HU0400325A patent/HUP0400325A3/hu unknown
-
2005
- 2005-01-31 AT AT05708499T patent/ATE420882T1/de not_active IP Right Cessation
- 2005-01-31 EP EP08008434A patent/EP1950213B1/fr active Active
- 2005-01-31 RS RSP-2006/0427A patent/RS20060427A/sr unknown
- 2005-01-31 JP JP2006550312A patent/JP2007519700A/ja active Pending
- 2005-01-31 DE DE602005012365T patent/DE602005012365D1/de not_active Expired - Fee Related
- 2005-01-31 EA EA200601417A patent/EA010830B1/ru not_active IP Right Cessation
- 2005-01-31 EP EP05708499A patent/EP1711501B1/fr active Active
- 2005-01-31 AT AT08008434T patent/ATE438647T1/de not_active IP Right Cessation
- 2005-01-31 WO PCT/HU2005/000008 patent/WO2005073235A2/fr active Application Filing
- 2005-01-31 DE DE602005015902T patent/DE602005015902D1/de not_active Expired - Fee Related
-
2006
- 2006-09-01 NO NO20063917A patent/NO20063917L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HU0400325D0 (en) | 2004-04-28 |
EP1950213A3 (fr) | 2008-08-13 |
EP1711501A2 (fr) | 2006-10-18 |
WO2005073235A2 (fr) | 2005-08-11 |
EA010830B1 (ru) | 2008-12-30 |
HUP0400325A2 (hu) | 2005-09-28 |
EP1950213B1 (fr) | 2009-08-05 |
ATE438647T1 (de) | 2009-08-15 |
EP1950213A2 (fr) | 2008-07-30 |
JP2007519700A (ja) | 2007-07-19 |
EA200601417A1 (ru) | 2006-12-29 |
DE602005012365D1 (de) | 2009-03-05 |
ATE420882T1 (de) | 2009-01-15 |
DE602005015902D1 (de) | 2009-09-17 |
HUP0400325A3 (en) | 2005-11-28 |
EP1711501B1 (fr) | 2009-01-14 |
WO2005073235A3 (fr) | 2005-10-06 |
RS20060427A (en) | 2008-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2009260044B2 (en) | A process for the preparation of the apoptosis promoter ABT-263 | |
JP4319245B2 (ja) | ヒスタミン−3受容体拮抗薬 | |
US5756817A (en) | O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same | |
EP1527048B1 (fr) | Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique | |
ES2199433T5 (es) | 3,3-diarilpropilaminas, su uso y preparacion. | |
AU2004247487B2 (en) | N-pyrrolidin-3-YL-amide derivatives as serotonin and noradrenaline re-uptake inhibitors | |
OA11572A (en) | PyrroloÄ2,3-düpyrimidine compounds. | |
US20130158265A1 (en) | Sitagliptin, salts and polymorphs thereof | |
WO1998015526A1 (fr) | Composes de o-carbamoyl-phenylalaninol, sels de ces composes utiles sur le plan pharmaceutique, et procede de preparation de ces derniers | |
WO2018191815A1 (fr) | Procédés de préparation d'acalabrutinib, et ses intermédiaires | |
NO20063917L (no) | Fremgangsmate for syntese av N-[3-(3-cyanopyrazol[1,5A]pyrimidin-7-yl)-fenyl]-N-etyl-acetamid | |
JPS58172379A (ja) | 新規なキナゾリン誘導体 | |
CA2189964A1 (fr) | Nouveau derive de diaminomethylidene | |
JP6368043B2 (ja) | 三環式ラクタム化合物の製造法 | |
CN113121417A (zh) | 一种新型哌啶衍生物及其药物用途 | |
WO2009084031A2 (fr) | Procédé amélioré de préparation de la forme polymorphe a du (2e)-2-cyano-3-(3,4-dihydroxy-5-nitrophényl)-n,n-diéthyl-2-propènamide | |
KR102611847B1 (ko) | 무스카린 수용체 길항 활성을 갖는 신규한 피롤리디늄 화합물 및 이의 용도 | |
CN1441802A (zh) | 用以治疗阳痿的吡唑并嘧啶酮衍生物的制备方法 | |
EP1716129A1 (fr) | Derives de la piperazine presentant une activite en tant qu'inhibiteurs du recaptage de la serotonine et de la noradrenaline | |
KR100998067B1 (ko) | 비스(1-[(4-클로로페닐)페닐메틸]피페라진)-2,3-디벤조일 타르타르산 신규 중간체 염 및 이를 이용한 광학 활성적으로 순수한 1-[(4-클로로페닐)페닐메틸]피페라진을 분리하는 분리방법 | |
CA3232921A1 (fr) | Oximes et leur utilisation dans le traitement de maladies associees a gba | |
WO2010092286A1 (fr) | Derives de n-[(2-aza-bicyclo[2.1.1]hex-1-yl]-aryl-methyl]-benzamide, leur preparation et leur application en therapeutique | |
NO843307L (no) | Cykloheksankarbonksylsyrer og derivater derav | |
JP2007197397A (ja) | 多置換エチレンジアミン誘導体の製造方法 | |
CA2751866A1 (fr) | Derives de n-[(6-aza-bicyclo[3.2.1]oct-1-yl)-aryl-methyl]-benzamide, leur preparation et leur application en therapeutique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |